Employees: 539
Size Shanghai Sanyou Medical (688085.SS) is a China Health Care company (Medical Specialties) with a market value of $692M, the 2919th largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥12.66 on 18 Nov 2026.
Performance Over six months the shares fell 22.9%, against -12.4% for the median peer and -20.0% for the China market (cap-weighted) — 7th lowest of 21 in its peer set.
Growth Revenue grew 15.4% over the last twelve months (peer median +14.1%); the operating margin is 4.2% (peer median 13.7%).
Valuation It trades at 50.0× forward earnings against a peer median of 21.7× (3rd most expensive of 17).
Price implies For today's price to make sense, revenue must grow about 29% a year for seven years (Req g). Recent delivered growth is +7%, so the hurdle is +22 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 3.5 points below its cost of capital (6.7% WACC).
Next results Next results expected around 27 Apr 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥591M | CN¥539M | CN¥450M | CN¥457M | CN¥642M |
| Revenue growth | — | +20% | -1% | -29% | — |
| Gross profit | CN¥476M | CN¥373M | CN¥292M | CN¥349M | CN¥566M |
| EBITDA | n/a | CN¥110M | CN¥67.3M | CN¥156M | CN¥207M |
| Net income | CN¥48.5M | CN¥63.1M | CN¥11.5M | CN¥95.6M | CN¥191M |
| Free cash flow | CN¥31.6M | CN¥41.5M | -CN¥23.7M | CN¥243M | CN¥26.7M |
| Capital expenditure | CN¥40.7M | CN¥28.9M | CN¥37.4M | CN¥25.9M | CN¥138M |
| Total debt | CN¥72.4M | CN¥56.0M | CN¥54.0M | CN¥4.99M | CN¥5.39M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 688085.SS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -1.0% | -8.9% | 6th highest of 21 |
| 6-month return | -22.9% | -12.4% | 7th lowest of 21 |
| Distance from 52-week high | -41.6% | -35.5% | 9th lowest of 21 |
| Revenue growth (TTM) | +15.4% | +14.1% | 10th highest of 21 |
| Operating margin | 4.2% | 13.7% | 7th lowest of 21 |
| Forward P/E | 50.0× | 21.7× | 3rd most expensive of 17 |
| Growth the price implies (Req g, 7 yrs) | 29.0% | 6.6% | 3rd most demanding of 16 |
| Growth delivered (Del g) | +6.8% | +14.2% | 5th lowest of 16 |
| Hurdle (Req g minus delivered) | +22.2 pp | -12.4 pp | 2nd most demanding of 16 |
| ROIC minus cost of capital | -3.5 pp | +3.8 pp | 6th lowest of 21 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Shanghai Sanyou Medical 688085.SS | China | $692M | -23% | +15% | 4% | 50.0× | 29.0% | +6.8% |
| Shenzhen Lifotronic Technology 688389.SS | China | $692M | -14% | +14% | 13% | 29.9× | 11.6% | +13.3% |
| Anhui Hongyu Wuzhou Medical Manufacturer 301234.SZ | China | $697M | +148% | -14% | 3% | n/a | 31.8% | -0.6% |
| Livsmed 491000.KS | South Korea | $687M | -47% | +89% | -77% | n/a | n/a | n/a |
| Delcath Systems DCTH | United States | $685M | +75% | +38% | 5% | 358.9× | 33.4% | +120.2% |
| Shanghai INT Medical Instruments 1501.HK | Hong Kong | $700M | -25% | +35% | 21% | 15.9× | -3.3% | +23.5% |
| Japan Lifeline 7575.T | Japan | $703M | +34% | +6% | 19% | 14.5× | -9.5% | +2.9% |
| Shenzhen Sunnypol Optoelectornics 002876.SZ | China | $680M | -9% | +29% | 5% | 39.0× | 10.1% | +14.2% |
| SWS Hemodialysis Care 688410.SS | China | $706M | -11% | +31% | 19% | 23.5× | 16.2% | +25.9% |
| Doctorglasses Chain 300622.SZ | China | $710M | -22% | +6% | 14% | 22.8× | -3.4% | +15.7% |
| Caina Technology 301122.SZ | China | $721M | +36% | +61% | 0% | 55.4× | n/a | n/a |
| Shanghai Kinetic Medical 300326.SZ | China | $662M | -10% | -28% | 17% | 26.0× | 6.6% | -1.9% |
| Synektik SNT.WA | Poland | $662M | +10% | +32% | 24% | 13.8× | 0.2% | +47.5% |
| QuidelOrtho QDEL | United States | $657M | -20% | -5% | -2% | 10.7× | n/a | n/a |
| Shanghai Aladdin Biochemical Technology 688179.SS | China | $736M | -37% | +39% | 24% | 27.4× | 17.1% | +24.2% |
| BMC Medical 301367.SZ | China | $737M | -17% | +37% | 17% | 18.7× | -1.5% | +15.6% |
| Beijing Aerospace Changfeng 600855.SS | China | $738M | -44% | -10% | -19% | n/a | n/a | n/a |
| InMode INMD | United States | $741M | -8% | +2% | 18% | 9.8× | -10.8% | +12.4% |
| Shanghai Runda Medical Technology 603108.SS | China | $744M | -36% | -12% | -2% | 20.5× | 20.3% | -0.2% |
| Jiang Xi Sanxin Medtec 300453.SZ | China | $744M | -3% | +12% | 18% | 16.2× | -1.9% | +11.8% |
| Allmed Medical Products 002950.SZ | China | $747M | -32% | +14% | 8% | n/a | n/a | n/a |